Aptamer Group Plc (GB:APTA) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Aptamer Group Plc has reported significant progress following a successful £2.6 million fundraising, achieving cost reduction targets and expanding its commercial partnerships with major pharmaceutical firms. The company is advancing its product development, notably working with AstraZeneca on a fibrosis platform and Unilever on a deodorant product. New contracts worth £471,000 have bolstered the company’s financial position, allowing for future growth and licensing opportunities.
For further insights into GB:APTA stock, check out TipRanks’ Stock Analysis page.
